Is younger better? Donor age less than 25 does not predict more favorable outcomes after in vitro fertilization
To determine whether younger oocyte donor age is associated with better outcomes after in vitro fertilization (IVF) compared with older oocyte donor age.
A retrospective cohort study.
Large academically affiliated infertility treatment center.
We included all women ≥ 18 years who started their first fresh cycle using donor oocytes at our center from January 2002 through October 2017; only the first oocyte recipient cycle was analyzed.
Log-binomial regression was used to compare the incidence of clinical pregnancy and live birth among the following donor age groups: < 25 years, 25 to < 30 years, and 30 to <35 years.
Main outcome measure
Incidence of clinical pregnancy and live birth among donor age groups.
We included 774 donor cycles; 269 (34.8%) used donors < 25 years, 399 (51.6%) used donors 25 to < 30 years, and 106 (13.7%) used donors 30 to < 35 years. Median donor age was 26 years (range 18–34.5), and median recipient age and partner age were both 42 years. Per cycle start, after adjusting for recipient age, cycles using donors < 25 years were not associated with a higher incidence of clinical pregnancy (RR 0.90; 95% CI 0.77–1.06) or live birth (RR 0.87; 95% CI 0.72–1.04) compared with donors age 25–< 30 years.
Donor age < 25 was not associated with better outcomes after IVF. Under the age of 30, the prioritization of <25 year old donors may not be recommended given the lack of evidence for superior pregnancy or live birth outcomes.
KeywordsIVF Oocyte donation Live birth Assisted reproductive technology Age
This work was conducted with financial support from Harvard Catalyst | The Harvard Clinical and Translational Science Center (National Center for Research Resources and the National Center for Advancing Translational Sciences, National Institutes of Health Award 1UL1 TR001102-01) and financial contributions from Harvard University and its affiliated academic health care centers.
Compliance with ethical standards
The institutional review board at Beth Israel Deaconess Medical Center approved this study.
- 1.Budak E, Garrido N, Soares SR, Melo MA, Meseguer M, Pellicer A, et al. Improvements achieved in an oocyte donation program over a 10-year period: sequential increase in implantation and pregnancy rates and decrease in high-order multiple pregnancies. Fertil Steril. 2007;88(2):342–9.CrossRefGoogle Scholar
- 22.Harris KFO, Paul RC, Macaldowie A, Lee E, Chambers GM. Assisted reproductive technology in Australia and New Zealand 2014. Sydney: National Perinatal Epidemiology and Statistics Unit, the University of New South Wales; 2016.Google Scholar
- 23.Wang YA MA, Hayward I, Chambers GM, Sullivan EA. Assisted reproductive technology in Australia and New Zealand 2009. Australian Institute of Health and Welfare 2011;Assisted reproduction technology series no. 15.Google Scholar
- 24.Franasiak JM, Forman EJ, Hong KH, Werner MD, Upham KM, Treff NR, et al. The nature of aneuploidy with increasing age of the female partner: a review of 15,169 consecutive trophectoderm biopsies evaluated with comprehensive chromosomal screening. Fertil Steril. 2014;101(3):656–663 e1.CrossRefGoogle Scholar